| Pathogenetic mechanisms in thyroid follicular-cell neoplasia T Kondo, S Ezzat, SL Asa Nature Reviews Cancer 6 (4), 292-306, 2006 | 1148 | 2006 |
| Epithelial splicing regulatory proteins 1 (ESRP1) and 2 (ESRP2) suppress cancer cell motility via different mechanisms H Ishii, M Saitoh, K Sakamoto, T Kondo, R Katoh, S Tanaka, M Motizuki, ... Journal of Biological Chemistry 289 (40), 27386-27399, 2014 | 183 | 2014 |
| The Associations Between RAS Mutations and Clinical Characteristics in Follicular Thyroid Tumors: New Insights from a Single Center and a Large Patient Cohort M Fukahori, A Yoshida, H Hayashi, M Yoshihara, S Matsukuma, ... Thyroid 22 (7), 683-689, 2012 | 177 | 2012 |
| Expression of aquaporin 3 (AQP3) in normal and neoplastic lung tissues YL Liu, T Matsuzaki, T Nakazawa, S Murata, N Nakamura, T Kondo, ... Human pathology 38 (1), 171-178, 2007 | 139 | 2007 |
| Transcription factor Runx2 is a regulator of epithelial–mesenchymal transition and invasion in thyroid carcinomas DF Niu, T Kondo, T Nakazawa, N Oishi, T Kawasaki, K Mochizuki, ... Laboratory investigation 92 (8), 1181-1190, 2012 | 123 | 2012 |
| Clinicopathological implications of MET exon 14 mutations in non-small cell lung cancer–a systematic review and meta-analysis HG Vuong, ATN Ho, AMA Altibi, T Nakazawa, R Katoh, T Kondo Lung Cancer 123, 76-82, 2018 | 113 | 2018 |
| Hypoxia-inducible adenosine A2B receptor modulates proliferation of colon carcinoma cells DF Ma, T Kondo, T Nakazawa, DF Niu, K Mochizuki, T Kawasaki, ... Human pathology 41 (11), 1550-1557, 2010 | 113 | 2010 |
| Epigenetic silencing of TTF-1/NKX2-1 through DNA hypermethylation and histone H3 modulation in thyroid carcinomas T Kondo, T Nakazawa, D Ma, D Niu, K Mochizuki, T Kawasaki, ... Laboratory investigation 89 (7), 791-799, 2009 | 108 | 2009 |
| Differences in surgical resection rate and risk of malignancy in thyroid cytopathology practice between Western and Asian countries: a systematic review and meta‐analysis HG Vuong, HTT Ngo, A Bychkov, CK Jung, TH Vu, KB Lu, K Kakudo, ... Cancer cytopathology 128 (4), 238-249, 2020 | 107 | 2020 |
| Molecular alterations of coexisting thyroid papillary carcinoma and anaplastic carcinoma: identification of TERT mutation as an independent risk factor for transformation N Oishi, T Kondo, A Ebina, Y Sato, J Akaishi, R Hino, N Yamamoto, ... Modern Pathology 30 (11), 1527-1537, 2017 | 94 | 2017 |
| Global histone modification of histone H3 in colorectal cancer and its precursor lesions T Nakazawa, T Kondo, D Ma, D Niu, K Mochizuki, T Kawasaki, T Yamane, ... Human pathology 43 (6), 834-842, 2012 | 91 | 2012 |
| Epigenetically controlled fibroblast growth factor receptor 2 signaling imposes on the RAS/BRAF/mitogen-activated protein kinase pathway to modulate thyroid cancer progression T Kondo, L Zheng, W Liu, J Kurebayashi, SL Asa, S Ezzat Cancer research 67 (11), 5461-5470, 2007 | 87 | 2007 |
| RET gene rearrangements (RET/PTC1 and RET/PTC3) in papillary thyroid carcinomas from an iodine‐rich country (Japan) T Nakazawa, T Kondo, Y Kobayashi, N Takamura, S Murata, ... Cancer: Interdisciplinary International Journal of the American Cancer …, 2005 | 86 | 2005 |
| The changing characteristics and molecular profiles of papillary thyroid carcinoma over time: a systematic review HG Vuong, AMA Altibi, AH Abdelhamid, PUD Ngoc, VD Quan, ... Oncotarget 8 (6), 10637, 2017 | 82 | 2017 |
| Absence of human papillomavirus infection in minimal deviation adenocarcinoma and lobular endocervical glandular hyperplasia JY Xu, A Hashi, T Kondo, T Yuminamochi, M Nara, K Hashi, SI Murata, ... International journal of gynecological pathology 24 (3), 296-302, 2005 | 78 | 2005 |
| Prognostic significance of diffuse sclerosing variant papillary thyroid carcinoma: a systematic review and meta-analysis HG Vuong, T Kondo, TQ Pham, N Oishi, K Mochizuki, T Nakazawa, ... European Journal of Endocrinology 176 (4), 433-441, 2017 | 74 | 2017 |
| Magnetic resonance elastography is as accurate as liver biopsy for liver fibrosis staging H Morisaka, U Motosugi, S Ichikawa, T Nakazawa, T Kondo, S Funayama, ... Journal of Magnetic Resonance Imaging 47 (5), 1268-1275, 2018 | 72 | 2018 |
| The cancer/testis antigen melanoma-associated antigen-A3/A6 is a novel target of fibroblast growth factor receptor 2-IIIb through histone H3 modifications in thyroid cancer T Kondo, X Zhu, SL Asa, S Ezzat Clinical Cancer Research 13 (16), 4713-4720, 2007 | 68 | 2007 |
| Lobular endocervical glandular hyperplasia as a presumed precursor of cervical adenocarcinoma independent of human papillomavirus infection M Nara, A Hashi, SI Murata, T Kondo, T Yuminamochi, K Nakazawa, ... Gynecologic oncology 106 (2), 289-298, 2007 | 65 | 2007 |
| Expression of CD73 and its ecto‐5′‐nucleotidase activity are elevated in papillary thyroid carcinomas T Kondo, T Nakazawa, SI Murata, R Katoh Histopathology 48 (5), 612-614, 2006 | 64 | 2006 |
Naoki OISHIDepartment of Pathology, University of YamanashiVerified email at yamanashi.ac.jp
